This company is a blank-check SPAC with no operations, no revenue, and no identified acquisition target. The company raised $115M in its October 2025 IPO, with proceeds held in a trust invested in U.S. government securities while management searches for a deal. The company focuses on the food and beverage sector, with a preference for targets in Asia and particularly China, reflecting the management team's ties to the PRC. The target enterprise value range is $200M–$1B. The sponsor received 2,875,000 founder shares for $25,000 — representing roughly 20% of post-IPO equity — creating a strong incentive to close a deal. Public investors get downside protection through redemption rights at approximately $10.025 per share and upside through warrants exercisable at $11.50. The company has 18 months to complete a deal, extendable to 24 months, after which the trust is liquidated and warrants expire worthless. The China-focused mandate introduces deal risk, including PRC regulatory exposure and U.S.-China geopolitical friction. The company has also ruled out targets using a VIE structure, which is common among U.S.-listed Chinese companies, further narrowing the pool of candidates.